Bob Smith
Venture Partner
Bio
Bob joined OrbiMed in 2024 as a Venture Partner. He brings over thirty years of experience in alliance management, business development, commercial, mergers and acquisitions, and research and development roles. Bob retired from Pfizer in January 2024 where he led Pfizer’s end-to-end global gene therapy business. In his other roles at Pfizer, he led the global business development activities for the R&D organization as well as the strategic transactions team. Bob also oversaw the business development and strategy teams for the Animal Health, Capsugel, Consumer Healthcare, and Nutrition divisions. He joined Pfizer in October 2009 after its acquisition of Wyeth, where he led the global mergers and acquisitions group. Bob is a member of the board of directors of various biotechnology companies and healthcare organizations. He obtained a B.S. in Neuroscience and an M.B.A. in Finance and Corporate Accounting from the University of Rochester.
Highlights:
- Serves as the Vice Chair of the Board of Directors of the Alliance for Regenerative Medicine and as a Senior Advisor to the Focused Ultrasound Foundation
- Loves traveling the world with his spouse, Barbara, and spending quality time with their three adult children, their spouses, and four grandkids
- Enjoys biking, hiking, skiing and swimming plus wine tasting in California’s Sonoma and Napa counties
